Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study

Abstract Background Thyroglobulin (Tg) is a specific tumor marker for differentiated thyroid cancer (DTC). However, in the presence of an antithyroglobulin antibody (TgAb), it becomes unreliable. The purpose of the study was to assess the long-term outcome of DTC patients with raised TgAb. Method In...

Full description

Bibliographic Details
Main Authors: Manish Ora, Aftab Hasan Nazar, Prabhakar Mishra, Sukanta Barai, Amitabh Arya, Prasanta Kumar Pradhan, Sanjay Gambhir
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Thyroid Research
Subjects:
Differentiated thyroid cancer
Serum antithyroglobulin antibody
Radioiodine therapy
Recurrence
Online Access:https://doi.org/10.1186/s13044-021-00099-w

Similar Items

Similar Items